References
- Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–439.
- Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2):218.e1–9.
- Hasegawa J, Tanaka H, Katsuragi S. et al. Maternal deaths in Japan due to abnormally invasive placenta. Int J Gynaecol Obstet. 2018;140(3):375–376.
- Shamshirsaz AA, Fox KA, Erfani H, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstetr Gynecol. 2017;216(6):612.e1–612.e5.
- Sargent W, Collins SL. Are women antenatally diagnosed with abnormally invasive placenta receiving optimal management in England? An observational study of planned place of delivery. Acta Obstet Gynecol Scand. 2019;98(3):337–341.
- Nieto AJ, Echavarría MP, Carvajal JA, et al. Placenta accreta: importance of a multidisciplinary approach in the Colombian hospital setting. J Maternal-Fetal Neonatal Med.2020;33(8):1321–1329.
- Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561–568.
- Nieto-Calvache AJ, López-Girón MC, Messa-Bryon A, et al. Urinary tract injuries during treatment of patients with morbidly adherent placenta. J Matern Fetal Neonatal Med. 2019 Oct 21:1–7.
- Nieto A, Zambrano M, Herrera N, et al. Resective-reconstructive treatment of abnormally invasive placenta: Inter Institutional Collaboration by telemedicine (eHealth). J Matern Neonatal Med. 2019:27:1–9. .
- Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51(12):2627–2633.
- Norris BL, Everaerts W, Posma E, et al. The urologist's role in multidisciplinary management of placenta percreta. BJU Int. 2016;117(6):961–965.
- Solheim KN, Esakoff TF, Little SE, et al. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Neonatal Med. 2011;24(11):1341–1346.
- Mogos MF, Salemi JL, Ashley M, et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-Associated costs, 1998-2011. J Matern Neonatal Med. 2016;29(7):1077–1082.
- Panigrahi AK, Yeaton-Massey A, Bakhtary S, et al. A standardized approach for transfusion medicine support in patients with morbidly adherent placenta. Anesth Analg. 2017;125(2):603–608.
- Allen L, Jauniaux E, Hobson S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet. 2018;140(3):281–290.
- Shamshirsaz AA, Fox KA, Erfani H, et al. The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta. Clin Obstet Gynecol. 2018;61(4):841–850.
- Volochovič J, Ramašauskaitė D, Šimkevičiūtė R. Clinical aspects and antenatal diagnosis of invasive placenta: a review of ten-years’ experience of a multi-profile hospital in Lithuania. Acta Medica Litu. 2017;24(3):176–187.
- Kilic A. Understanding variability in hospital-specific. J Thorac Cardiovasc Surg. 2014;147(1):109–15.
- Murphy WS. Higher volume surgeons have lower medicare payments, readmissions, and mortality after THA. Clin Orthop Relat Res. 2019;477(2):334–341.